A biological perspective of breast cancer: contributions of the National Surgical Adjuvant Breast and Bowel Project clinical trials.
Fisher
B
B
Department of Surgery, University of Pittsburgh School of Medicine, Pennsylvania.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery*; D002278:Carcinoma in Situ / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007414:Intestinal Neoplasms / Q000601:surgery; D008197:Lymph Node Excision; D015409:Mastectomy, Radical; D015412:Mastectomy, Segmental; D009313:National Health Programs; D013629:Tamoxifen / Q000627:therapeutic use; D014481:United States
D013629:Tamoxifen; D004317:Doxorubicin; D003520:Cyclophosphamide